1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（微信公众号信息）：

https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/

4、投稿系统：

https://www2.cloud.editorialmanager.com/rerere/default2.aspx

5、官网电话：0755-82552914

6、官网邮箱：edit-office@reg-rep-reh.com

7、出刊日期：季刊，一年出版四期。

8、官方微信公众号：RegRepReh Journal

9、官网信息：2027年12月31日前投稿免收文章处理费

2026年5月6日星期三

Guide for Authors

【官网信息】

Introduction

Types of paper

Research Article (Word limit: 5000-7000)

A complete report on original research and/or clinical studies

A structured abstract is required.

A clear structure is required, which should contain but not confined to the following sections:

Introduction

Material and methods

Results

Discussion

Conclusions

Authors' contribution (For details please visit the link.)

Ethic statement

COI

(acknowledgments/clarification)

Bibliography

Appendices (including multimedia components)

Review

Article (Word limit: 7000-9000) A substantial overviews present a

complete overview of the state of the art with a comprehensive

bibliography, generally, also contains a table of contents. It should

cover topics that have seen significant development or progress in

recent years, with comprehensive depth and a balanced perspective.

Review articles should NOT include unpublished material such as

unpublished/original data, submitted manuscripts, or personal

communication.

Editorial (Word limit: 1000)

Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.

Short Communication (Word limit: 2000)

Short

report or announcement of research, usually claiming certain results,

which present original and significant material for rapid dissemination.

Short Communications are expected to have a higher than average impact

on the field rather than report on incremental research.

Guideline/Consensus (Word limit: 10000) (for clinical medicine only)

Guidelines:

documents that have been locally or internationally approved and

contain general principles that may benefit others in their clinical

practice or in writing their own guidelines.

Consensus:

evidence-based analyses of issues that integrate findings, ideas and/or

conceptual frameworks from a variety of sources in a clear and balanced

way.

Meeting Reports, News & Announcements (Word limit: 1500)

Meeting

reports Summary of a relevant symposium, workshop, etc. Or, information

about a conference (can be a description of the venture, but also a

visit report of a scientist who has attended a conference).

Letter to the Editor (Word limit: 2000)

Any

items of interest to the wide audience of the publication. The items

includes a letter to the editor commenting on previously published

articles or a reply to the letter. (The letter or reply needs a

"refers-to" DOI or PII number; or argumentative communication, like

papers in a discussion, or commentaries, etc.(Subsequent discussion

papers need a "refers-to" DOI or PII number).

Perspective (Word limit: 3000)

An

article presents a new and unique viewpoint on existing problems,

fundamental concepts, or prevalent notions on a specific topic, propose

and support a new hypothesis, or discuss the implications of a newly

implemented innovation. Perspective pieces may focus on current advances

and future directions on a topic and may include original data as well

as personal opinion.

As

a guideline, Perspective should not normally exceed 3,000 words.

Perspectives allow up to 30 references; citations should be selective.

Perspectives should include no more than 4 display items (figures,

tables and/or boxes).

Submission checklist

You

can use this list to carry out a final check of your submission before

you send it to the journal for review. Please check the relevant section

in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

E-mail address

Full postal address

All necessary files have been uploaded:

Manuscript:

Include keywords

All figures (include relevant captions)

All tables (including titles, description, footnotes)

Ensure all figure and table citations in the text match the files provided

Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

Manuscript has been 'spell checked' and 'grammar checked'

All references mentioned in the Reference List are cited in the text, and vice versa

Permission has been obtained for use of copyrighted material from other sources (including the Internet)

A competing interests statement is provided, even if the authors have no competing interests to declare

Journal policies detailed in this guide have been reviewed

Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

Before you begin

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Submissions

to KeAi journals are automatically screened using iThenticate's

CrossCheck within the editorial system to detect plagiarism issues

including instances of overlapping and similar text in submitted

manuscripts. Details can be found here. High similarity papers will be

desk rejected.

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)

include the name of the ethics committee that approved the study and the committee's reference number if appropriate

All

materials must adhere to high ethical and animal welfare standards. Any

use of animals must be based on ethological knowledge and respect for

species-specific requirements for health and well-being. A statement

indicating that the protocol and procedures employed were ethically

reviewed and approved, and the name of the body giving approval, must be

included in the Methods section of the manuscript.

Consent for publication

If

your research or manuscript contains any individual person's data in

any form (including any individual details, images or videos), consent

for publication must be obtained from that person, or in the case of

children, their parent or legal guardian. All presentations of case

reports must have consent for publication.

Studies in humans and animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

Authors should include a statement in the manuscript that informed

consent was obtained for experimentation with human subjects. The

privacy rights of human subjects must always be observed. All animal

experiments should comply with the ARRIVE guidelines and should be

carried out in accordance with the U.K. Animals (Scientific Procedures)

Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal

experiments, or the National Institutes of Health guide for the care and

use of Laboratory animals (NIH Publications No. 8023, revised 1978) and

the authors should clearly indicate in the manuscript that such

guidelines have been followed. The sex of animals must be indicated, and

where appropriate, the influence (or association) of sex on the results

of the study.

Declaration of interests

All

authors must disclose any financial and personal relationships with

other people or organizations that could inappropriately influence

(bias) their work. Examples of potential conflicts of interest include

employment, consultancies, stock ownership, honoraria, paid expert

testimony, patent applications/registrations, and grants or other

funding. Authors should complete the declaration of competing interest

statement using this template and upload to the submission system at the

Attach/Upload Files step. Note: Please do not convert the .docx

template to another file type. Author signatures are not required. If

there are no interests to declare, please choose the first option in the

template. This statement will be published within the article if

accepted. More information.

Submission declaration and verification

Submission

of an article implies that the work described has not been published

previously (except in the form of an abstract or as part of a published

lecture or academic thesis or as an electronic preprint, see 'Multiple,

redundant or concurrent publication' section of our ethics policy for

more information), that it is not under consideration for publication

elsewhere, that its publication is approved by all authors and tacitly

or explicitly by the responsible authorities where the work was carried

out, and that, if accepted, it will not be published elsewhere in the

same form, in English or in any other language, including electronically

without the written consent of the copyright-holder. To verify

originality, your article automatically screened by the originality

detection service CrossCheck.

Use of inclusive language

Inclusive

language acknowledges diversity, conveys respect to all people, is

sensitive to differences, and promotes equal opportunities. Content

should make no assumptions about the beliefs or commitments of any

reader; contain nothing which might imply that one individual is

superior to another on the grounds of age, gender, race, ethnicity,

culture, sexual orientation, disability or health condition; and use

inclusive language throughout. Authors should ensure that writing is

free from bias, stereotypes, slang, reference to dominant culture and/or

cultural assumptions. We advise to seek gender neutrality by using

plural nouns ("clinicians, patients/clients") as default/wherever

possible to avoid using "he, she," or "he/she." We recommend avoiding

the use of descriptors that refer to personal attributes such as age,

gender, race, ethnicity, culture, sexual orientation, disability or

health condition unless they are relevant and valid. These guidelines

are meant as a point of reference to help identify appropriate language

but are by no means exhaustive or definitive.

Please

write your text in good English (American or British usage is accepted,

but not a mixture of these). Authors who feel their English language

manuscript may require editing to eliminate possible grammatical or

spelling errors and to conform to correct scientific English may wish to

use the English Language Editing service available from Elsevier's

WebShop.

Preprints

Please

note that preprints can be shared anywhere at any time, in line with

Elsevier's sharing policy. Sharing your preprints e.g. on a preprint

server will not count as prior publication (see 'Multiple, redundant or

concurrent publication' for more information).

Authorship Statement

For

transparency, we encourage authors to submit an author statement file

outlining their individual contributions to the paper using the relevant

CRediT roles: Conceptualization; Data curation; Formal analysis;

Funding acquisition; Investigation; Methodology; Project administration;

Resources; Software; Supervision; Validation; Visualization;

Roles/Writing – original draft; Writing – review & editing.

Authorship statements should be formatted with the names of authors

first and CRediT role(s) following.

Sample CRediT author statement

Zhang

San: Conceptualization, Methodology, Software Priya Singh: Data

curation, Writing- Original draft preparation. Wang Wu: Visualization,

Investigation. Jan Jansen: Supervision. Ajay Kumar: Software,

Validation. Sun Qi: Writing- Reviewing and Editing.

More information can be viewed here.

Changes to authorship

This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

Before

the accepted manuscript is published in an online issue: Requests to

add or remove an author, or to rearrange the author names, must be sent

to the Journal Manager from the corresponding author of the accepted

manuscript and must include: (a) the reason the name should be added or

removed, or the author names rearranged and (b) written confirmation

(e-mail, fax, letter) from all authors that they agree with the

addition, removal or rearrangement. In the case of addition or removal

of authors, this includes confirmation from the author being added or

removed. Requests that are not sent by the corresponding author will be

forwarded by the Journal Manager to the corresponding author, who must

follow the procedure as described above. Note that: (1) Journal Managers

will inform the Journal Editors of any such requests and (2)

publication of the accepted manuscript in an online issue is suspended

until authorship has been agreed.

After

the accepted manuscript is published in an online issue: Any requests

to add, delete, or rearrange author names in an article published in an

online issue will follow the same policies as noted above and result in a

corrigendum.

Clinical trial results

In

line with the position of the International Committee of Medical

Journal Editors, the journal will not consider results posted in the

same clinical trials registry in which primary registration resides to

be prior publication if the results posted are presented in the form of a

brief structured (less than 500 words) abstract or table. However,

divulging results in other circumstances (e.g., investors' meetings) is

discouraged and may jeopardise consideration of the manuscript. Authors

should fully disclose all posting in registries of results of the same

or closely related work.

Observational Study Reporting Guidelines

Observational Study Reporting Guidelines

In

order to improve the quality and transparency of health research, it is

recommended that all studies adhere to specific guidelines prior to

submission. For more information, please visit:

https://www.equator-network.org/reporting-guidelines/

Reporting clinical trials

Randomized

controlled trials should be presented according to the CONSORT

guidelines. At manuscript submission, authors must provide the CONSORT

checklist accompanied by a flow diagram that illustrates the progress of

patients through the trial, including recruitment, enrollment,

randomization, withdrawal and completion, and a detailed description of

the randomization procedure. The CONSORT checklist is available online.

Registration of clinical trials

Registration

in a public trials registry is a condition for publication of clinical

trials in this journal in accordance with International Committee of

Medical Journal Editors recommendations. Trials must register at or

before the onset of patient enrolment. The clinical trial registration

number should be included at the end of the abstract of the article. A

clinical trial is defined as any research study that prospectively

assigns human participants or groups of humans to one or more

health-related interventions to evaluate the effects of health outcomes.

Health-related interventions include any intervention used to modify a

biomedical or health-related outcome (for example drugs, surgical

procedures, devices, behavioural treatments, dietary interventions, and

process-of-care changes). Health outcomes include any biomedical or

health-related measures obtained in patients or participants, including

pharmacokinetic measures and adverse events. Purely observational

studies (those in which the assignment of the medical intervention is

not at the discretion of the investigator) will not require

registration.

Copyright

This

journal is a peer-reviewed, fully open access journal owned by The

First Affiliated Hospital of Shenzhen University, who retains copyright

of the overall compiled journal and the compiled issues. For the single

article, Authors will retain copyright alongside scholarly usage rights,

and KeAi Communications Co., Ltd. and The First Affiliated Hospital of

Shenzhen University will be granted non-exclusive publishing and

distribution rights.

Elsevier supports responsible sharing

Find out how you can share your research published in Elsevier journals.

Role of the funding source

You

are requested to identify who provided financial support for the

conduct of the research and/or preparation of the article and to briefly

describe the role of the sponsor(s), if any, in study design; in the

collection, analysis and interpretation of data; in the writing of the

report; and in the decision to submit the article for publication. If

the funding source(s) had no such involvement then this should be

stated. Please see https://www.elsevier.com/open-access/agreements.

Open Access

Every

peer-reviewed research article appearing in this journal will be

published open access. This means that the article is universally and

freely accessible via the internet in perpetuity, in an easily readable

format immediately after publication. The open access publication fee

for this journal is USD 1500, plus taxes. All APCs for articles

submitted to the journal before the 31-12-2027 will be fully waived.

A

CC user license manages the reuse of the article. All articles will be

published under one of the following licenses upon author choice, for

more details please visit link

(https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/open-access-journal/).

Declaration of generative AI in scientific writing

Authors

are encouraged to declare the use of generative AI in scientific

writing upon submission of the paper. The following guidance refers only

to the writing process, and not to the use of AI tools to analyse and

draw insights from data as part of the research process:

Generative

AI and AI-assisted technologies should only be used in the writing

process to improve the readability and language of the manuscript.

The

technology must be applied with human oversight and control and authors

should carefully review and edit the result, as AI can generate

authoritative-sounding output that can be incorrect, incomplete or

biased. Authors are ultimately responsible and accountable for the

contents of the work.

Authors

must not list or cite AI and AI-assisted technologies as an author or

co-author on the manuscript since authorship implies responsibilities

and tasks that can only be attributed to and performed by humans.

The

use of generative AI and AI-assisted technologies in scientific writing

can be declared by adding a statement at the end of the manuscript when

the paper is first submitted. The statement will appear in the

published work and should be placed in a new section before the

references list. An example:

Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.

Statement:

During the preparation of this work the author(s) used [NAME TOOL /

SERVICE] in order to [REASON]. After using this tool/service, the

author(s) reviewed and edited the content as needed and take(s) full

responsibility for the content of the published article.

The

declaration does not apply to the use of basic tools, such as tools

used to check grammar, spelling and references. If you have nothing to

disclose, you do not need to add a statement.

We advise you to read our policy for authors on the use of generative AI and AI-assisted technologies for Elsevier.

Please

note: to protect authors’ rights and the confidentiality of their

research, this journal does not currently allow the use of Generative AI

or AI-assisted technologies such as ChatGPT or similar services by

reviewers or editors in the peer review and manuscript evaluation

process. We are actively evaluating compliant AI tools and may revise

this policy in the future.

Elsevier Researcher Academy

Researcher

Academy is a free e-learning platform designed to support early and

mid-career researchers throughout their research journey. The "Learn"

environment at Researcher Academy offers several interactive modules,

webinars, downloadable guides and resources to guide you through the

process of writing for research and going through peer review. Feel free

to use these free resources to improve your submission and navigate the

publication process with ease.

Submission

Submission

to this journal proceeds totally online. Use the following guidelines

to prepare your article. Via the homepage of this journal

(https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/)

you will be guided stepwise through the creation and uploading of the

various files. The system automatically converts source files to a

single Adobe Acrobat PDF version of the article, which is used in the

peer-review process. Please note that even though manuscript source

files are converted to PDF at submission for the review process, these

source files are needed for further processing after acceptance. All

correspondence, including notification of the Editor's decision and

requests for revision, takes place by e-mail and via the author's

homepage, removing the need for a hard-copy paper trail. If you are

unable to provide an electronic version, please contact the editorial

office prior to submission:

Email: edit-office@reg-rep-reh.com

Tel: +86-755-82552914

ORCiD

ID: Our journal supports the use of ORCiD ID. Authors are encouraged to

provide ORCiD ID at submission. Authors are encouraged to provide ORCiD

ID at submission.

......

更多详见：

https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/guide-for-authors/#gfa-instruction-22